Literature DB >> 21212548

Study of the pseudo-crystalline transformation from form i to form II of thiamine hydrochloride (vitamin B(1)).

Katsuhiko Masuda1, Takayuki Ishige, Hiroyuki Yamada, Kotaro Fujii, Hidehiro Uekusa, Keiko Miura, Etsuo Yonemochi, Katsuhide Terada.   

Abstract

The purpose of the current study was to evaluate the rate of the pseudo-crystalline transformation of thiamine hydrochloride form I to form II depending on the temperature and humidity. Changes in the appearance and weight of form I crystals were observed under humidified conditions using a water vapor sorption system equipped with a CCD camera. The form I crystals and tablets were stored under various temperature and humidity conditions (the saturation salt desiccator method), and the pseudo-crystalline transformation was observed using X-ray powder diffractometry with our laboratory equipment for drug substances and using synchrotron X-ray powder diffractometry for tablets. It was confirmed that the activation energy in the pseudo-crystalline transformation rate from form I to form II was dependent on humidity, and the calculated values were 121-155 kJ/mol at 70-90% relative humidity. Moreover, when thiamine hydrochloride was formulated as tablets, it was confirmed that the transformation rate was slower compared with the drug substances alone. The pseudo-crystalline transformation rate therefore declined after formulation in tablet form, perhaps due to the shielding effects of thiamine hydrochloride crystal from contact with water molecules by excipients, compaction, etc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212548     DOI: 10.1248/cpb.59.57

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  1 in total

1.  Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction.

Authors:  Kenji Egusa; Fumiaki Okazaki; Joerg Schiewe; Ulrike Werthmann; Markus Wolkenhauer
Journal:  Drugs R D       Date:  2017-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.